Population-Specific Haplotype Association of the Postsynaptic Density Gene DLG4 with Schizophrenia, in Family-Based Association Studies

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Balan, Shabeesh ^a   Yamada, Kazuo ^a   Hattori, Eiji ^a   Iwayama, Yoshimi ^a   Toyota, Tomoko ^a   Ohnishi, Tetsuo ^a   Maekawa, Motoko ^a   Toyoshima, Manabu ^a   Iwata, Yasuhide ^b   Suzuki, Katsuaki ^b   Kikuchi, Mitsuru ^c   Yoshikawa, Takeo ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POSTSYNAPTIC DENSITY PROTEIN 95;

ADULT; ALLELE; ARTICLE; AUTOPSY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DLG1 GENE; DLG4 GENE; FAMILY STUDY; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MDM2 GENE; MOLECULAR PHYLOGENY; PATHOGENESIS; PEDIGREE ANALYSIS; PICK1 GENE; POPULATION GENETICS; POSTSYNAPTIC DENSITY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; POST-SYNAPTIC DENSITY; PROTO-ONCOGENE PROTEINS C-MDM2; SCHIZOPHRENIA; SYNAPSES;

EID: 84880807529     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070302     Document Type: Article

References (51)

1. Cardno AG, Gottesman II, (2001) Twin studies of schizophrenia: From bow-and-arrow concordances to Star Wars Mx and functional genomics. American journal of medical genetics 97: 12-17.
2. Balu DT, Coyle JT, (2011) Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neuroscience & Biobehavioral Reviews 35: 848-870.
3. Egerton A, M Stone J, (2012) The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development. Current Pharmaceutical Biotechnology 13: 1500-1512.
4. Goto Y, Yang CR, Otani S, (2010) Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biological psychiatry 67: 199-207.
5. Stephan KE, Baldeweg T, Friston KJ, (2006) Synaptic plasticity and dysconnection in schizophrenia. Biological psychiatry 59: 929-939.
6. Stephan KE, Friston KJ, Frith CD, (2009) Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophrenia Bulletin 35: 509-527.
7. Javitt DC, Zukin SR, (1991) others (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
8. Tsai G, Coyle JT, (2002) Glutamatergic mechanisms in schizophrenia. Annual Review of Pharmacology and Toxicology 42: 165-179.
9. Itokawa M, Yamada K, Yoshitsugu K, Toyota T, Suga T, et al. (2003) A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics and Genomics 13: 271-278.
10. Boeckers TM, (2006) The postsynaptic density. Cell and tissue research 326: 409-422.
11. Ting JT, Pecca J, Feng G, (2012) Functional Consequences of Mutations in Postsynaptic Scaffolding Proteins and Relevance to Psychiatric Disorders. Annual Review of Neuroscience 35: 49-71.
12. Iasevoli F, Tomasetti C, de Bartolomeis A (2012) Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases. Neurochemical Research: 1-22.
13. Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, et al. (1998) Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396: 433-439.
14. Beneyto M, Meador-Woodruff JH, (2006) Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia. Synapse 60: 585-598.
15. Cheng MC, Lu CL, Luu SU, Tsai HM, Hsu SH, et al. (2010) Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia. PloS one 5: e15107.
16. Chen L, Chetkovich DM, Petralia RS, Sweeney NT, Kawasaki Y, et al. (2000) Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 408: 936-943.
17. Ehrlich I, Malinow R, (2004) Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. The Journal of neuroscience 24: 916-927.
18. El-Husseini AED, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS, (2000) PSD-95 involvement in maturation of excitatory synapses. Science 290: 1364-1368.
19. Lau CG, Zukin RS, (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nature Reviews Neuroscience 8: 413-426.
20. Lin Y, Skeberdis VA, Francesconi A, Bennett MVL, Zukin RS, (2004) Postsynaptic density protein-95 regulates NMDA channel gating and surface expression. The Journal of neuroscience 24: 10138-10148.
21. Xu W, Schlüter OM, Steiner P, Czervionke BL, Sabatini B, et al. (2008) Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD. Neuron 57: 248-262.
22. Anggono V, Huganir RL (2012) Regulation of AMPA receptor trafficking and synaptic plasticity Current opinion in neurobiology.
23. Dev KK, Henley JM, (2006) The schizophrenic faces of PICK1. Trends in pharmacological sciences 27: 574.
24. Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, et al. (2003) Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 40: 595-607.
25. Lussier MP, Nasu-Nishimura Y, Roche KW, (2011) Activity-dependent ubiquitination of the AMPA receptor subunit GluA2. The Journal of Neuroscience 31: 3077-3081.
26. Klei L, Bacanu SA, Myles-Worsley M, Galke B, Xie W, et al. (2005) Linkage analysis of a completely ascertained sample of familial schizophrenics and bipolars from Palau, Micronesia. Human genetics 117: 349-356.
27. Yamada K, Iwayama Y, Hattori E, Iwamoto K, Toyota T, et al. (2011) Genome-wide association study of schizophrenia in Japanese population. PloS one 6: e20468.
28. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, et al. (2008) Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. The American Journal of Human Genetics 83: 445-456.
29. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
30. Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, et al. (2006) Distinguishable Haplotype Blocks in the HTR3A and HTR3B Region in the Japanese Reveal Evidence of Association of HTR3B with Female Major Depression. Biological psychiatry 60: 192-201.
31. Yamada K, Nakamura K, Minabe Y, Iwayama-Shigeno Y, Takao H, et al. (2004) Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biological psychiatry 56: 683-690.
32. Devlin B, Roeder K, (2004) Genomic control for association studies. Biometrics 55: 997-1004.
33. Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, et al. (2009) Preliminary genome-wide association study of bipolar disorder in the Japanese population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150: 1110-1117.
34. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. The American Journal of Human Genetics 74: 106-120.
35. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological): 289-300.
36. Kawashima R, Ohnuma T, Shibata N, Arai H, (2006) No genetic association between postsynaptic density-95 gene polymorphisms and schizophrenia. Neuroscience letters 400: 168-171.
37. Tsai SJ, Hong CJ, Cheng CY, Liao DL, Liou YJ, (2007) Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia. Journal of Neural Transmission 114: 423-426.
38. Catts VS, Weickert CS, (2012) Gene expression analysis implicates a death receptor pathway in schizophrenia pathology. PLoS One 7: e35511.
39. Zheng S, Gray EE, Chawla G, Porse BT, O'Dell TJ, et al. (2012) PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nature neuroscience 15: 381-388.
40. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
41. Bergen S, O'Dushlaine C, Ripke S, Lee P, Ruderfer D, et al. (2012) Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Molecular psychiatry 17: 880-886.
42. Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, et al. (2005) Serine racemase binds to PICK1: potential relevance to schizophrenia. Molecular psychiatry 11: 150-157.
43. Hong CJ, Liao DL, Shih HL, Tsai SJ, (2004) Association study of PICK1 rs3952 polymorphism and schizophrenia. Neuroreport 15: 1965-1967.
44. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, et al. (2011) Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. American Journal of Psychiatry 168: 302-316.
45. Magri C, Sacchetti E, Traversa M, Valsecchi P, Gardella R, et al. (2010) New copy number variations in schizophrenia. PLoS One 5: e13422.
46. Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, et al. (2010) Microdeletions of 3q29 confer high risk for schizophrenia. The American Journal of Human Genetics 87: 229-236.
47. Sato J, Shimazu D, Yamamoto N, Nishikawa T, (2008) An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia. Journal of Neural Transmission 115: 1355-1365.
48. Uezato A, Kimura-Sato J, Yamamoto N, Iijima Y, Kunugi H,et al. (2012) Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia. Behav Brain Funct 8.
49. Carroll LS, Williams HJ, Walters J, Kirov G, O'Donovan MC, et al. (2011) Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156: 844-849.
50. Ishiguro H, Koga M, Horiuchi Y, Inada T, Iwata N, et al. (2007) PICK1 is not a susceptibility gene for schizophrenia in a Japanese population: Association study in a large case-control population. Neuroscience research 58: 145-148.
51. Liu N, Zhang K, Zhao H, (2008) Haplotype-Association Analysis. Advances in genetics 60: 335-405.